Table 3 Deceased patients’ characteristics
Deceased n = 159 (26.5%) | Alive n = 440 (73.5%) | P-value | |
|---|---|---|---|
Age (mean ± SD, range) | 63.9 ± 14.2 (21–93) | 59.1 ± 15.3 (16.5–90) | p < 0.001 |
Gender | |||
Female | 75 (47.2%) | 288 (65.5%) | p < 0.001 |
Cancer location | p < 0.001 | ||
Genitourinary (GU) | 27 (17.0%) | 53 (12%) | |
Sarcoma | 27 (17.0%) | 40 (9%) | |
Gastrointestinal (GI) | 21 (13.2%) | 42 (9.5%) | |
Gynecologic (Gyn) | 21 (13.2%) | 29 (6.6%) | |
Breast | 20 (12.6%) | 161 (36.6%) | |
Thyroid | 11 (6.9%) | 42 (9.5%) | |
Lung | 8 (5.0%) | 4 (0.9%) | |
Hematologic (Hem) | 8 (5.0%) | 33 (7.5%) | |
Melanoma | 6 (3.8%) | 12 (2.7%) | |
Other | 10 (6.3%) | 24 (5.5%) | |
BNP elevation | 139 (89.1%) | 324 (74.1%) | p < 0.001 |
LV dysfunction | |||
LVEF < 50% | 33 (20.8%) | 74 (16.8%) | p = 0.267 |
GFR < 60 ml/min/1.73m2 | 39 (24.5%) | 80 (18.2%) | p = 0.086 |
TSAT (mean ± SD, range, %), | 21.9 ± 16.3 (3.0–99.0) | 23.3 ± 13.2 (4.0–94.0) | p = 0.313 |
Median | 20 | 20 | |
Ferritin (μg/L) (mean ± SD, range) | 245 ± 319.4 (11.0–1500) | 167.4 ± 287.3 (6–1500) | p = 0.005 |
Ferritin < 100 μg/L | 71 (44.6%) | 272 (61.8%) | |
Ferritin ≥ 100 μg/L | 87 (54.7%) | 165 (37.5%) | |
Serum iron (umol/L)(mean ± SD.range) | 12.6 ± 8.2 (1.6–54.2) | 14.9 ± 7.7 (1.7–76) | p = 0.002 |
Iron < 12 umol/L | 93 (58.5%) | 159 (36.1%) | |
Anemia | 94 (59.1%) | 150 (34.1%) | p = 0.740 |